# Abbvie Biotechnology Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/abbvie-biotechnology-ltd/b438b15a-033c-469a-8973-66b6506bba41

> Inspection records and compliance data for Abbvie Biotechnology Ltd. in Barceloneta, Puerto Rico. Access full analysis and detailed observations.

---

## Details

- Name: Abbvie Biotechnology Ltd.
- FEI Number: 3004620772
- City: Barceloneta
- State: Puerto Rico
- Country Name: United States
- Address Line 1: Road No 2 Km 59.2
- Zip Code: 00617

## Related Documents

- [483 - Abbvie Biotechnology Ltd. - Unknown Date](https://www.keypedia.com/records/483/abbvie-biotechnology-ltd/b841e8d1-f95e-4ef1-bf9f-48c8f728cd44) — source: FDA, date: Invalid Date
- [483 - Abbvie Biotechnology Ltd. - 2023-10-30](https://www.keypedia.com/records/483/abbvie-biotechnology-ltd/9720fdfe-bc68-465d-82ae-4663e933a7ae) — source: FDA, date: October 30, 2023
- [483 - Abbvie Biotechnology Ltd. - 2023-10-30](https://www.keypedia.com/records/483/abbvie-biotechnology-ltd/fc6e7103-fba8-48a2-aaec-eae25e1f9e30) — source: FDA, date: October 30, 2023
- [FDA Inspection 1222107 - Abbvie Biotechnology Ltd. - 2023-10-30](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/fbc58704-0c5e-4f2c-8caa-a8e38cd2ba1a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2023
- [EIR - Abbvie Biotechnology Ltd. - 2019-03-25](https://www.keypedia.com/records/eir/abbvie-biotechnology-ltd/60b66384-af33-4ed5-93d8-e8d6f46a6c62) — source: FDA, date: March 25, 2019
- [483 - Abbvie Biotechnology Ltd. - 2019-03-25](https://www.keypedia.com/records/483/abbvie-biotechnology-ltd/21216898-f0d2-4e1d-a352-c04132283cdb) — source: FDA, date: March 25, 2019
- [FDA Inspection 1084057 - Abbvie Biotechnology Ltd. - 2019-03-25](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/8a1c2a7f-d230-419e-8259-9a4045db92d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2019
- [FDA Inspection 1055102 - Abbvie Biotechnology Ltd. - 2018-06-01](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/6ebd3fac-5fb5-4657-a309-9546c0d43e1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018
- [FDA Inspection 1012249 - Abbvie Biotechnology Ltd. - 2017-04-28](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/086cba85-e6e5-48ec-a35e-02b4f9600118) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2017
- [EIR - Abbvie Biotechnology Ltd. - 2017-01-13](https://www.keypedia.com/records/eir/abbvie-biotechnology-ltd/b46b0168-1899-4d02-b119-b2104039df67) — source: FDA, date: January 13, 2017
- [FDA Inspection 969277 - Abbvie Biotechnology Ltd. - 2016-03-24](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/5800f07b-684a-4070-bd7c-4ec2bbc0b14f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 24, 2016
- [FDA Inspection 887947 - Abbvie Biotechnology Ltd. - 2014-07-16](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/0aeefd43-5395-44aa-82c5-ebf1fb1a8c67) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 16, 2014
- [FDA Inspection 791758 - Abbvie Biotechnology Ltd. - 2012-07-12](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/f0aad22a-29ca-4979-9fe3-413e39afee79) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 12, 2012
- [FDA Inspection 720207 - Abbvie Biotechnology Ltd. - 2011-04-29](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/cdd40822-5b41-43d4-b781-326202615310) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 29, 2011
- [FDA Inspection 575712 - Abbvie Biotechnology Ltd. - 2009-03-04](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/8fcf6dbb-ba7a-4b7f-92ba-567c15b038ba) — classification: No Action Indicated (NAI), source: FDA, date: March 4, 2009

## Related Companies

- [Purolea Cosmetics Lab](https://www.keypedia.com/companies/purolea-cosmetics-lab/a2662a80-cd8c-4da0-bd8d-6cd4ea6079c6)
- [Rentschler Biopharma SE](https://www.keypedia.com/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)
- [Chugai Pharma Manufacturing Co. Ltd.](https://www.keypedia.com/companies/chugai-pharma-manufacturing-co-ltd/09ba6515-9227-444c-a24c-a6cb8da9e235)
- [Sanofi Winthrop Industrie](https://www.keypedia.com/companies/sanofi-winthrop-industrie/f7668868-7954-441c-b8bf-ab135e8645c2)
- [Takeda Manufacturing Italia SPA](https://www.keypedia.com/companies/takeda-manufacturing-italia-spa/1998fa46-5f10-426b-b959-5378f2b887e1)
- [BSP Pharmaceuticals SpA](https://www.keypedia.com/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc)
- [Regeneron Pharmaceuticals Inc](https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7)
- [Hovione LLC](https://www.keypedia.com/companies/hovione-llc/06b4417a-5377-4e73-8076-71d3066fa8f0)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.keypedia.com/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/85fd73c7-1b97-4ac5-bc70-53dfb31c37e5)

## Related Officers

- [Ramesh Potla](https://www.keypedia.com/people/ramesh-potla/0df722fa-b514-49ac-8fcd-58363e086d32)
- [Principal Consultant- CMC Biologics, Former FDA regulator with expertise in CMC and GMP for Biologics](https://www.keypedia.com/people/steven-e-bowen/0e32c7e6-285b-4cf1-90e1-8a7a12a38b0c)
- [Investigator](https://www.keypedia.com/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f)
- [Lilia M Lugo](https://www.keypedia.com/people/lilia-m-lugo/bd409997-f589-4d2d-b7ba-4b52f222e43e)